BioMedical Enterprises, Inc. Announces Rory Gleadhill as Vice President of Sales and Marketing

SAN ANTONIO, July 23 /PRNewswire/ -- BioMedical Enterprises, Inc. (BME), a rapidly growing medical device company focused on the clinical development of orthopaedic nitinol implants, announced today that it has appointed Rory Gleadhill as their Vice President of Sales and Marketing. Rory brings over 25 years of experience in the Orthopaedic Medical Device Industry with significant knowledge and experience in Trauma, Spine and Total Joint markets. He has been involved in the development and launch of over 40 products. He spent many years with Smith & Nephew and was Vice President of Spine and Biologics at Interpore Cross International.

BME specializes in nitinol implants that contract and compress bone after implantation, bringing bone ends together to promote bone union. The unique aspect of BME’s intellectual property is that for the first time the surgeon can control the amount of compression and rate of force application these nitinol implants generate on bones intra-operatively.

“I am delighted to welcome Rory to our management team. Our sales have been growing very rapidly and Rory has the leadership, creativity and drive required to attain our aggressive sales goals and lead our new product launches. We have significant new product and market opportunities and his skills will be fully exploited as we maximize them,” said W. Casey Fox, PhD, P.E., Founder and Chief Executive Officer of BME.

“I am very pleased to be joining this very innovative company with its unique patented technology. Dr. Fox has already proven the clinical value of the technology and developed a very successful sales and marketing organization. I look forward to building on this strong sales base, strengthening its leadership position in its existing markets and to open new ones,” said Rory Gleadhill.

BioMedical Enterprises, Inc. (BME) is a medical device company that addresses the changing needs in musculoskeletal medicine. BME focuses on minimally invasive orthopaedic instrumentation and implants that elicit a biologic response. BME’s focus on memory metal internal fixation implants is changing the shape of orthopaedic medicine. Its specialized history of musculoskeletal research services will continue to produce unique, state of the art orthopaedic products that provide better outcomes for patients and more convenience to surgeons. For more information, visit http://www.bme-tx.com.

BioMedical Enterprises, Inc.

CONTACT: Eric Marcano of BioMedical Enterprises, Inc., 1-800-880-6528

MORE ON THIS TOPIC